Lehrstuhl für Haut- und Geschlechtskrankheiten

The involvement of Toll-like receptor 9 in the pathogenesis of erosive autoimmune arthritis (2018) Fischer A, Abdollahi-Roodsaz S, Boehm C, Niederreiter B, Meyer B, Yau ACY, Lonnblom E, et al. Journal article MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance (2018) Lai X, Gupta SK, Schmitz U, Marquardt S, Knoll S, Spitschak A, Wolkenhauer O, et al. Journal article, Original article Model-Based Phenotypic Signatures Governing the Dynamics of the Stem and Semi-differentiated Cell Populations in Dysplastic Colonic Crypts (2018) Nikolov S, Santos Rosales G, Wolkenhauer O, Vera J Journal article Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score (2018) Holtsche MM, Goletz S, Van Beek N, Zillikens D, Benoit S, Harman K, Walton S, et al. Journal article Neuromuscular Side Effects of Immune Checkpoint Inhibitors (2018) Moreira A, Loquai C, Knauss S, Gutzmer R, Dimitriou F, Meier F, Heppt M, et al. Conference contribution Melanocytes as an emerging key player in niche regulation of limbal stem cells (2018) Schlötzer-Schrehardt U, Polisetti N, Zenkel M, Naschberger E, Heger L, Dudziak D, Stürzl M, Kruse F Conference contribution Ex vivo expanded NK Cells from Melanoma Patients receive their Migration in a 3D Model and lyse autologous Melanoma Cells (2018) Rossner S, Czerwinski T, Mark C, Gross S, Karg M, Bosch JJ, Schuler-Thurner B, et al. Conference contribution Extracellular Vesicles in the Plasma of Melanoma Patients under-press beta Catenin in Tumor Cells by using miRNA-34a (2018) Baur A, Lee JH, Dindorf J, Eberhardt M, Lai X, Ostalecki C, Koliha N, et al. Conference contribution Eosinophilic Fasciitis by Treatment with Checkpoint Inhibitors in metastatic Melanoma (2018) Toussaint F, Erdmann M, Moreira A, Kirchberger MC, Schuler G, Heinzerling L Conference contribution Expression of Senescence Markers - Is Predictive for Immune Therapy with Checkpoint Inhibitors? (2018) Moreira A, Gross S, Kirchberger MC, Erdmann M, Schuler G, Heinzerling L Conference contribution